← Back to Search

LCHF, Ketogenic Diet for Obesity

N/A
Waitlist Available
Led By Shebani Sethi Dalai, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,16 weeks
Awards & highlights

Study Summary

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness

Eligible Conditions
  • Obesity
  • Metabolic Syndrome
  • Ketogenic Diet
  • Bipolar Disorder
  • Schizophrenia
  • Psychotropic Medication Side Effects
  • Brain Metabolic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline,16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in blood pressure from baseline
Change in body fat mass from baseline
Change in heart rate from baseline
+9 more
Secondary outcome measures
Generalized Anxiety Disorder - GAD-7 Anxiety
Patient Health Questionnaire - PHQ-9 Depression
Pittsburgh Sleep Quality Index - PSQI
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ketogenic Diet 16 Week GroupExperimental Treatment1 Intervention
Patients follow ketogenic diet for 16 weeks, with monitoring of physical and psychological health and coaching support

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,985 Total Patients Enrolled
69 Trials studying Obesity
270,213 Patients Enrolled for Obesity
Shebani Sethi Dalai, MDPrincipal Investigator - Stanford University
Stanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
Neuroscience & Biobehavioral ReviewsJournal
Ketogenic Diet as a Metabolic Therapy for Mood Disorders: Evidence and Developments
Brietzke, Elisa, Rodrigo B. Mansur, Mehala Subramaniapillai, Vicent Balanzá-Martínez, Maj Vinberg, Ana González-Pinto, Joshua D. Rosenblat, Roger Ho, and Roger S. McIntyre. 2018. “Ketogenic Diet as a Metabolic Therapy for Mood Disorders: Evidence and Developments”. Neuroscience & Biobehavioral Reviews. Elsevier BV. doi:10.1016/j.neubiorev.2018.07.020.
clinicaltrials.govStudy
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness
Shebani Sethi 2019. "Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03935854.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top